Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT03003468
Status:
COMPLETED
Last Update Posted:
2024-08-13
First Post:
2016-12-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
Sponsor:
Lawrence Feldman, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-22
First Submit QC Date:
None
Study First Post Date:
2016-12-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-12-04
Results First Submit QC Date:
None
Results First Post Date:
2024-08-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18
Last Update Post Date:
2024-08-13
Last Update Post Date Type:
ACTUAL